[This corrects the article DOI: 10.3389/fimmu.2023.1326078.].
Keywords: PD-1/PD-L1 immune checkpoint inhibitors; autoimmune disease (AID); autoimmune hepatitis (AIH); autoimmune liver diseases (AILD); immune checkpoint inhibitors (ICI); immune related adverse effects (irAEs); primary biliary cholangitis (PBC); primary sclerosing cholangites (PSC).
Copyright © 2024 Kocheise, Piseddu, Vonderlin, Tjwa, Buescher, Meunier, Goeggelmann, Fianchi, Dumortier, Barciela, Gevers, Beretta-Piccoli, Londoño, Frankova, Roesner, Joerg, Schmidt, Glaser, Sutter, Fründt, Lohse, Huber, von Felden, Sebode and Schulze.